The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis

…, K Herlyn, P Seo, R Suppiah, G Tomasson… - The Journal of …, 2011 - jrheum.org
There has been a marked increase in the past 15 years in the number and quality of clinical
trials in the idiopathic inflammatory vasculitides, especially the small-vessel vasculitides …

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

…, R Sivakumar, X Tian, G Tomasson… - Annals of the …, 2020 - ard.bmj.com
… In patients with GCA with acute visual loss or amaurosis fugax, the administration of 0.25–1
g intravenous methylprednisolone for up to 3 days should be considered, because these …

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda

…, T Neogi, P Seo, R Suppiah, G Tomasson… - The Journal of …, 2011 - jrheum.org
Giant cell (GCA) and Takayasu’s arteritis (TAK) are 2 forms of large-vessel vasculitis (LVV)
that involve the aorta and its major branches. GCA has a predilection for the cranial branches, …

Thromboembolic disease in vasculitis

G Tomasson, PA Monach… - Current opinion in …, 2009 - journals.lww.com
Thrombosis is an important clinical manifestation of some types of vasculitis. Better
understanding of the association of thrombosis with inflammation in vasculitis might lead to …

Association of stress-related disorders with subsequent autoimmune disease

H Song, F Fang, G Tomasson, FK Arnberg… - Jama, 2018 - jamanetwork.com
… Dr Tomasson reported receiving personal fees from Pfizer and Abbvie. Dr Mataix-Cols
reported receiving personal fees from UpToDate, Wolters Kluwer Health, and Elsevier and grants …

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis

G Tomasson, PC Grayson, AD Mahr, M LaValley… - …, 2012 - academic.oup.com
Objective. The value of repeated ANCA measurements among patients with an established
diagnosis of ANCA-associated vasculitis (AAV) remains controversial. The aim of this study …

[HTML][HTML] Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study

…, E Eyţórsson, EM Frans, G Tómasson… - The Lancet Public …, 2022 - thelancet.com
Background Long-term mental and physical health consequences of COVID-19 (long
COVID) are a persistent public health concern. Little is still known about the long-term mental …

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

…, TM Clark, G Tomasson… - Annals of the …, 2012 - ard.bmj.com
… A latent class model with the optimal number of computer derived subgroups (latent
classes) was determined using model fit statistics, including the likelihood ratio G2, Akaike …

Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis

PA Monach, RL Warner, G Tomasson… - Annals of the …, 2013 - ard.bmj.com
Objective To identify circulating proteins that distinguish between active anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and remission in a manner …

Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study

G Tomasson, C Peloquin, A Mohammad… - Annals of internal …, 2014 - acpjournals.org
… We read with great interest the article by Tomasson et al. (1) indicating a high risk for
cardiovascular disease early after diagnosis of giant-cell arteritis (GCA). However the authors …